Skip to main content
    E

    eXoZymes, Inc. (EXOZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.92
    +0.09 (+2.35%)

    Market Cap: $35.64M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    eXoZymes, Inc. (EXOZ) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect eXoZymes (EXOZ) to earn -$1.19 per share in the fiscal year ending Dec 31, 2026. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.12.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$1.19
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$1.12
    EPS consensus, revenue $540000
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$1.19-$1.19 to -$1.191N/AN/A1
    Dec 31, 2027-$1.12-$1.12 to -$1.121$540000$540000 to $5400001

    Estimate Revisions

    No EPS estimate for the 2 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202700

    Frequently Asked Questions About EXOZ

    What is the EXOZ stock forecast?

    Consensus analyst estimates put eXoZymes's EPS at -$1.19 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from EXOZ next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.19, with estimates from -$1.19 to -$1.19 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.12, with estimates from -$1.12 to -$1.12 from 1 analyst.

    What revenue do analysts expect from eXoZymes next year?

    For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $540000, with estimates from $540000 to $540000.

    How many analysts cover EXOZ?

    1 analyst estimates EPS for eXoZymes for the fiscal year ending Dec 31, 2026.